BackBruker Overview

Bruker Receivables

Track Bruker's receivables ($540M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$542.70M
22.59% YoYΔ $-158.40M vs prior year quarter

Peer average

Loading

Bruker Receivables History

Loading

Bruker vs. peers: Receivables Comparison

Loading

Bruker Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bruker (BRKR) FAQ

Bruker (BRKR) currently reports a receivables of $540M as of March 2026. That compares with $700M in the prior-year period — down 22.6% year over year. Use the charts on this page to explore Bruker's receivables history and peer comparisons.

Bruker's receivables decreased from $700M to $540M — a 22.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bruker reported $540M in receivables as of March 2026. That compares with $700M in the prior-year period — down 22.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $540M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bruker, and consider following BRKR for alerts when major investors trade the stock.

Bruker is classified in the Healthcare sector. On receivables, it currently shows $540M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BRKR with unrelated industries.